 |
 |
 |
|
No Resistance to Tenofovir Alafenamide Detected Through 48 Weeks
of Treatment in Patients With Chronic Hepatitis B
|
|
|
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Henry Lik-Yuen Chan,1 Scott Fung,2 Andrea L. Cathcart,3 Yang Liu,3 Karin S. Ku,3 John F. Flaherty,3 Michael D. Miller,3 Anuj Gaggar,3 Kathryn M. Kitrinos,3 Young-Suk Lim,4 Maria Buti5
1The Chinese University of Hong Kong, Hong Kong; 2University of Toronto, Toronto General Hospital, Ontario, Canada; 3Gilead Sciences, Inc., Foster City, CA; 4Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; 5Vall d'Hebron Hospital, Barcelona, Spain






|
|
|
 |
 |
|
|